Skip to main content
. 2022 Aug 17;38(4):1027–1040. doi: 10.1093/ndt/gfac165

Table 1.

Standardized incidence pmp of patients starting KRT across countries in Europe in 2008–17

Annual percentage change
Country 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 Time perioda Time perioda Time perioda
Austria 174.6 169.5 156.4 155.7 155.5 157.7 144.8 156.9 152.7 141.0 2008–17: −1.71* (−2.65; −0.76)
Belgium—Dutch-speaking 198.5 211.9 199.0 185.5 188.5 185.0 174.5 174.6 178.5 173.6 2008–17: −1.96* (−2.75; −1.16)
Belgium—French-speaking 216.3 223.3 217.6 214.3 218.6 208.7 202.7 212.6 213.3 217.3 2008–17: −0.37 (−1.02; 0.29)
Denmark 140.4 147.5 131.7 126.0 135.0 127.4 144.2 124.0 130.7 131.5 2008–17: −0.84 (−2.23; 0.56)
Finland 100.5 87.2 87.4 86.5 83.6 88.6 85.3 95.5 102.1 97.5 2008–12: −3.51 (−9.04; 2.34) 2012–17: 4.08 (−0.17; 8.51)
France 165.7 168.3 168.5 165.2 167.2 171.9 172.8 175.8 172.5 177.7 2008–17: 0.72* (0.39; 1.05)
Greece 204.6 206.6 187.4 196.5 200.6 203.4 203.2 207.8 225.4 223.0 2008–10: −4.39 (−11.91; 3.77) 2010–17: 2.27* (1.15; 3.39)
Iceland 102.3 122.8 143.9 129.0 85.7 84.8 70.8 84.2 107.8 174.5 2008–10: 19.04 (−47.23; 168.54) 2010–14: −17.95 (−5.37; 23.23) 2014–17: 34.56 (−10.14; 102.1)
Norway 132.6 137.0 121.1 117.4 120.2 116.3 115.2 111.6 116.5 119.6 2008–17: −1.54* (−2.68; −0.39)
Spain—Andalusia 144.8 139.8 135.2 130.4 135.1 140.8 138.3 137.3 148.1 143.2 2008–11: −2.86 (−6.91; 1.37) 2011–17: 1.64* (0.18; 3.11)
Spain—Aragon 128.3 128.4 136.4 122.6 132.0 128.1 120.2 112.5 121.5 119.1 2008–17: −1.27* (−2.36; −0.17)
Spain—Asturias 116.6 123.2 113.7 128.6 109.0 140.1 126.7 139.1 168.7 130.0 2008–17: 2.70* (0.08; 5.39)
Spain—Basque country 106.8 129.4 108.0 107.2 115.2 116.0 105.5 113.0 117.1 103.7 2008–17: −0.47 (−2.20; 1.29)
Spain—Cantabria 110.2 109.9 134.5 108.9 108.1 85.5 99.7 104.5 98.6 109.0 2008–17: −1.57 (−4.27; 1.21)
Spain—Castile and Léon 123.6 114.5 111.1 108.9 108.4 97.8 106.1 104.2 108.3 106.5 2008–13: −3.48* (−5.22; −1.71) 2013–17: 1.63 (−0.94; 4.28)
Spain—Castile-La Mancha 106.3 102.9 120.0 105.2 108.7 110.0 130.8 117.3 144.4 135.2 2008–17: 3.14* (1.17; 5.14)
Spain—Catalonia 159.9 164.1 148.8 151.0 155.1 162.4 164.3 172.2 172.5 168.9 2008–17: 1.14* (0.10; 2.20)
Spain—Community of Madrid 139.7 132.9 126.3 128.2 124.5 142.2 147.9 143.6 151.9 152.3 2008–17: 1.78* (0.33; 3.26)
Spain—Extremadura 138.9 110.6 138.4 104.9 123.0 121.4 111.8 138.6 106.4 107.3 2008–17: −1.45 (−4.24; 1.42)
Spain—Galicia 143.2 127.1 127.1 134.3 124.1 129.0 128.4 128.4 130.6 134.2 2008–17: −0.27 (−1.33; 0.81)
Spain—Valencian region 157.5 163.2 161.8 148.4 159.1 142.8 163.0 158.1 188.0 152.9 2008–17: 0.47 (−1.44; 2.42)
Sweden 126.5 130.0 124.0 125.2 115.9 117.6 119.6 118.4 120.3 115.3 2008–17: −1.04* (−1.70; −0.39)
The Netherlands 136.5 132.7 130.2 128.3 129.6 123.6 121.4 123.2 121.7 114.7 2008–17: −1.60* (−2.00; −1.19)
UK—England, Northern Ireland and Wales 119.1 119.7 115.9 117.4 116.3 118.3 124.1 127.2 126.2 127.3 2008–12: −0.75 (−3.27; 1.84) 2012–15: 3.13 (−4.93; 11.87) 2015–17: −0.04 (−7.85; 8.43)
UK—Scotland 113.0 110.5 105.6 100.0 102.9 98.4 105.7 116.2 106.7 118.0 2008–12: −3.18 (−7.7; 1.56) 2012–17: 3.21 (−0.22; 6.76)
All countries 146.0 146.8 142.0 140.6 141.6 143.2 144.7 147.3 149.1 148.0 2008–11: −1.48 (−3.15; 0.21) 2011–17: 1.01* (0.43; 1.60)

This table shows the standardized incidence pmp of patients starting KRT for 25 countries and regions across Europe for each year between 2008 and 2017. The incidence is reported per million population (pmp), and standardized using the age and sex distribution of the EU28 population in 2015. ‘All countries’ represents the overall standardized incidence in all participating countries and regions together. To reflect the trends over time, the APC with corresponding 95% confidence interval is given for each time period. aTime periods are defined by a statistically significant join point and could therefore differ between countries and regions. Bold numbers and an asterisk (*) indicate whether the APC was statistically significant (P < .05).

APC, annual percentage change; KRT, kidney replacement therapy; pmp, per million population.